Sybill Raises $11M in Series A Funding to Enhance AI Sales Assistant Sybill provides an AI assistant tailored for sales teams, automating tasks such as meeting notes, call summaries, follow-up emails, and CRM updates.
Outpace Bio Raises $144M for AI-Driven Cell Therapy Development Outpace Bio plans to bring its lead program, OPB-101, to IND clearance and initiate dosing by 2025 for advanced platinum-resistant cancers.
Not Diamond Secures $2.3M for AI Model Routing Technology Not Diamond aims to transform how developers interact with AI by providing a tool that ensures each query is handled by the best-suited AI model, streamlining the integration and utilization of AI technologies across various applications.
Ema Boosts Series A Funding to $50M to Enhance Agentic AI for Enterprises Ema is pioneering the future of work with its innovative agentic AI technology, aiming to create the universal employee of the future that enhances workplace productivity and efficiency.
ReviR Therapeutics Secures $30M in Series A Funding for AI-Driven Drug Discovery ReviR Therapeutics integrates artificial intelligence with biopharmaceutical development to create targeted therapies for serious genetic diseases.
Trio Mobil Secures $26.5M in Growth Financing to Expand AI and IoT Safety Solutions Trio Mobil is revolutionizing workplace safety with its AI and IoT solutions, paving the way for safer, smarter, and more efficient operations globally.
Axle Automation Raises $2.5M in Seed Funding to Enhance AI-Powered Compliance Solutions Focused on innovating within the compliance sector, Axle Automation is committed to leveraging AI to enhance the effectiveness and accuracy of AML measures, helping clients maintain compliance in a dynamic regulatory environment.